Drug Type Small molecule drug |
Synonyms Celecoxib/Metformin/Valsartan |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), COX-2 inhibitors(Cyclooxygenase-2 inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Arkay Therapeutics LLCStartup |
Active Organization Arkay Therapeutics LLCStartup |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Molecular FormulaC24H29N5O3 |
InChIKeyACWBQPMHZXGDFX-QFIPXVFZSA-N |
CAS Registry137862-53-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Phase 1 | US | Arkay Therapeutics LLCStartup | 23 Sep 2018 |
Diabetes Mellitus, Type 2 | Phase 1 | US | Arkay Therapeutics LLCStartup | 23 Sep 2018 |
Hypertension | Phase 1 | US | Arkay Therapeutics LLCStartup | 23 Sep 2018 |
Obesity | Phase 1 | US | Arkay Therapeutics LLCStartup | 23 Sep 2018 |